Research and Markets: Global Thalasse...
Home  »  Community News  »  Research and Markets...
Aug
20
ragupathyrenganathan
Research and Markets: Global Thalassemia API Manufacturers, Marketed and Phase III Drugs Landscape 2015-2016
Pharma News
0

(http://www.researchandmarkets.com/research/t6db4p/thalassemiaglobal) has announced the addition of the “Thalassemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” report to their offering.

Thalassemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Thalassemia.

A key objective of The report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Thalassemia. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Thalassemia.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India. The research analysis also presents the global sales forecasts data till 2016.

Key Topics Covered:

  1. Indication Overview
  2. Marketed Drugs
  3. Marketed Details of Drugs by Application Type
  4. Marketed Details of Drugs (NDA) by Marketing Status
  5. Marketed Details of Drugs by Patent Expiration Timeline
  6. Active Pharmaceutical Ingredient (API) Manufacturers Assessment
  7. API Manufacturers by United States Drug Master File (US DMF) Status
  8. API Manufacturers by US DMF Status (Drug Specific)
  9. API Manufacturers in Europe by Country
  10. API Manufacturers in India by State
  11. API Manufacturers in China by Province
  12. Marketed Details of Approved Drugs by Geography
  13. Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
  14. API Manufacturers by US DMF Status (Drug Specific)
  15. Drugs Market Data and Forecasted Sales Figure (2012-2016)
  16. Marketed Drugs for Thalassemia
  17. Drug Name
  18. Drug Description
  19. Global Active Pharmaceutical Manufacturers for Drug
  20. Approval Status of Drug
  21. Patent and Exclusivity Details for Drug
  22. Company Profile and Financials
  23. Phase III Drugs for Thalassemia
  24. United States Drug Master File (DMF)
  25. Discontinued Drugs for Thalassemia
  26. Appendix

For more information visithttp://www.researchandmarkets.com/research/t6db4p/thalassemiaglobal

Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Leave a reply

You must be logged in to post a comment.